Results 91 to 100 of about 27,400 (229)

Incomplete ovarian tissue removal in female dogs and cats [PDF]

open access: yes, 2016
Incomplete ovariectomy (IO) is the unintentional partial or complete lack of removal of one or both ovaries during an ovariohysterectomy or ovariectomy procedure, and is often referred to as ‘ovarian remnant syndrome’.
Davies N. L.   +5 more
core   +1 more source

Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma

open access: yesBMC Research Notes
Differentiated thyroid cancer is the most common endocrinological malignancy. Radioiodine treatment has a clear benefit in locally aggressive and metastatic cancers. There are discussions about long-term and acute adverse events.
Barbora Havlínová   +3 more
doaj   +1 more source

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's) [PDF]

open access: yes, 2011
Objective Standard treatment for severe granulomatosis with polyangiitis (Wegener's) (GPA) is daily oral cyclophosphamide (CYC), a cytotoxic agent associated with ovarian failure.
Allen, Nancy B.   +13 more
core   +1 more source

Anti-Mullerian hormone: reality check [PDF]

open access: yesHuman Reproduction, 2013
Christine A, Clark   +2 more
openaire   +2 more sources

Imaging the developing human external and internal urogenital organs with light sheet fluorescence microscopy. [PDF]

open access: yes, 2020
Technological advances in three-dimensional (3D) reconstruction techniques have previously enabled paradigm shifts in our understanding of human embryonic and fetal development. Light sheet fluorescence microscopy (LSFM) is a recently-developed technique
Baskin, Laurence   +9 more
core  

Establishment of age-related AMH screening cutoffs in Chinese women with PCOS: a retrospective study using propensity score matching analysis

open access: yesBMC Endocrine Disorders
Background Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 5–18% of women worldwide. This disorder is characterized by two core pathological features: ovulatory dysfunction and hyperandrogenism.
Zhen Wang   +5 more
doaj   +1 more source

Anti-Mullarian Hormone As A Diagnostic Marker of Polycystic Ovary Syndrome

open access: yesPakistan Armed Forces Medical Journal
Objective: To determine the utility of Anti-mullerian hormone (AMH) as a diagnostic marker of Polycystic ovarian syndrome (PCOS). Study Design: Comparative cross-sectional study Place and Duration of the Study: Department of Chemical Pathology and ...
Shabana Abbas   +5 more
doaj   +1 more source

Predicting ovarian aging: anti-Mullerian hormone [PDF]

open access: yesHuman Reproduction, 2012
Andrew S, Blazar   +2 more
openaire   +2 more sources

Comparison of anti-Mullerian Hormone average between laparoscopic and treatment with clomiphene citrate in patients with polycystic ovarian syndrome [PDF]

open access: yes, 2016
زمینه و هدف: آنتی مولرین هورمون (AMH) در پاتوژنز سندرم پلی کیستیک تخمدان درگیر می باشد. هدف ما مقایسه میانگین AMH در 2 روش لاپاروسکوپی و درمان با کلومیفن سیترات جهت سنجش پاسخ تخمدانی بود.
Aghadavod, E., Farzadi, L., Nouri, M.
core   +1 more source

Home - About - Disclaimer - Privacy